Preoperative hormone therapy trials for breast cancer

Breast

Volumn 10, Issue 1, 2001, Pages 1-5

  Cheung, K L ^a   Robertson, J F R ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; ANTIESTROGEN; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; FORMESTANE; FULVESTRANT; GONADORELIN AGONIST; GOSERELIN; LETROZOLE; LEUPRORELIN; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; MASTECTOMY; OVARIECTOMY; PARTIAL MASTECTOMY; PERIOPERATIVE PERIOD; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SIDE EFFECT; TUMOR GROWTH;

EID: 0035146761     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2000.0201     Document Type: Review

References (40)

1. Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: The Scottish trial
2. Tamoxifen for early breast cancer: An overview of the randomised trials
3. Comparable effect of ovarian ablation and CMF chemotherapy in premenopausal hormone receptor positive breast cancer patients
4. Presence of a growth stimulating factor in serum following primary tumour removal in mice
5. Effect of local or systemic treatment prior to primary tumour on the production and response to a serum growth stimulating factor in mice
6. Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status
7. Effect of raloxifene on Ki67 and apoptosis
8. Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer
9. A partially-blind, randomised, multicentre study comparing the anti-tumour effects of single doses (50, 125 and 250 mg) of long-acting 'Faslodex' (ICI 182, 780) with tamoxifen in postmenopausal women with to surgery
10. Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer
11. Histological changes in breast cancers following primary systemic treatment with either letrozole or tamoxifen
12. Treatment of early localised breast cancer in elderly patients by tamoxifen
13. Tamoxifen as initial sole treatment of localised breast cancer in elderly women: A pilot study
14. Primary treatment of breast cancer in elderly women with tamoxifen
15. Tamoxifen as primary treatment of breast cancer in elderly or frail patients: A practical management
16. Tamoxifen as an alternative to surgical resection for selected geriatric patients with primary breast cancer
17. Indications for primary tamoxifen therapy in elderly women with breast cancer
18. Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease?
19. Treatment of breast cancer in elderly patients
20. Tamoxifen as primary treatment of breast cancer in elderly patients
21. Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance
22. Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer
23. Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer
24. Primary medical therapy for operable breast cancer
25. Primary (neoadjuvant) medical therapy: Introduction
26. Locally advanced breast cancer: Early results of a randomised trial of multimodal therapy versus initial hormone therapy
27. A human tumour model
28. Randomised trial chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study)
29. Assessment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer
30. Response to endocrine manipulation and oestrogen receptor concentration in large operable breast cancer
31. Primary systemic therapy for operable breast cancer
32. Letrozole as primary medical therapy for locally advanced and large operable breast cancer
33. Efficacy of anastrozole as neoadjuvant therapy in postmenopausal women with large operable breast cancers: Reductions in tumour volume
34. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
35. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
36. Assessment of response to therapy in advanced breast cancer
37. The primary use of endocrine therapies
38. Regarding: 'Valero V, Buzdar A U, Hortobagyi G N. Locally advanced breast cancer
39. Effects of short-term preoperative tamoxifen on steroid receptor and Ki67 expression in primary breast cancer: An immunocytochemical study